Literature DB >> 29776976

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab.

Savino Sciascia1, Elena Rubini1, Massimo Radin1, Irene Cecchi1, Daniela Rossi1, Dario Roccatello1.   

Abstract

Entities:  

Keywords:  B cells; antiphospholipid antibodies; antiphospholipid syndrome; systemic lupus erythematosus; treatment

Mesh：

Substances：

Year:  2018        PMID： 29776976     DOI： 10.1136/annrheumdis-2018-213496

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Disappearance of a strong triple positivity for antiphospholipid antibodies after treatment with anakinra.

Authors:  Erik Arnaud; Camille Soulier; Jean-Christophe Gris
Journal:  Haematologica       Date:  2018-10-25       Impact factor: 9.941

2.  Is there a role for immunosuppression in antiphospholipid syndrome?

Authors:  Ecem Sevim; Rohan Willis; Doruk Erkan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

4.  Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish Patients.

Authors:  Martina Frodlund; Tomas Walhelm; Charlotte Dahle; Christopher Sjöwall
Journal:  Front Med (Lausanne)       Date:  2021-02-24

5.  Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.

Authors:  Tomas Walhelm; Iva Gunnarsson; Rebecca Heijke; Dag Leonard; Estelle Trysberg; Per Eriksson; Christopher Sjöwall
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

Review 6.  Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.

Authors:  Bei-Bei Cui; Yun-Ru Tian; Xin-Yue Ma; Geng Yin; Qibing Xie
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

7.  16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Authors:  Hannah Cohen; Maria J Cuadrado; Doruk Erkan; Ali Duarte-Garcia; David A Isenberg; Jason S Knight; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; David J Williams; Rohan Willis; Scott C Woller; Danieli Andrade
Journal:  Lupus       Date:  2020-10       Impact factor: 2.911

Review 8.  Delivery of mRNA for regulating functions of immune cells.

Authors:  Jia Shi; Meng-Wen Huang; Zi-Dong Lu; Xiao-Jiao Du; Song Shen; Cong-Fei Xu; Jun Wang
Journal:  J Control Release       Date:  2022-03-23       Impact factor: 11.467
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.